Works matching IS 03407004 AND DT 2023 AND VI 72 AND IP 7

Results: 48

The landscape of objective response rate of anti-PD-1/L1 monotherapy across 31 types of cancer: a system review and novel biomarker investigating.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2483, doi. 10.1007/s00262-023-03441-3

By:

Mao, Yize;
Xie, Hui;
Lv, Minyi;
Yang, Qiuxia;
Shuang, Zeyu;
Gao, Feng;
Li, Shengping;
Zhu, Lina;
Wang, Wei

Publication type:

Article

Combined therapeutic effect of YHO-1701 with PD-1 blockade is dependent on natural killer cell activity in syngeneic mouse models.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2473, doi. 10.1007/s00262-023-03440-4

By:

Takahashi, Hiroyuki;
Miyoshi, Nao;
Murakami, Hisashi;
Okamura, Yuta;
Ogo, Naohisa;
Takagi, Akimitsu;
Muraoka, Daisuke;
Asai, Akira

Publication type:

Article

CD33 BiTE<sup>®</sup> molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2499, doi. 10.1007/s00262-023-03439-x

By:

Marcinek, Anetta;
Brauchle, Bettina;
Rohrbacher, Lisa;
Hänel, Gerulf;
Philipp, Nora;
Märkl, Florian;
Strzalkowski, Thaddäus;
Lacher, Sonja M.;
Udiljak, Dragica;
Spiekermann, Karsten;
Theurich, Sebastian;
Kobold, Sebastian;
Kischel, Roman;
James, John R.;
Bücklein, Veit L.;
Subklewe, Marion

Publication type:

Article

Multidisciplinary recommendations for essential baseline functional and laboratory tests to facilitate early diagnosis and management of immune-related adverse events among cancer patients.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 1991, doi. 10.1007/s00262-023-03436-0

By:

Özdemir, Berna C.;
Espinosa da Silva, Cristina;
Arangalage, Dimitri;
Monney, Pierre;
Guler, Sabina A.;
Huynh-Do, Uyen;
Stirnimann, Guido;
Possamai, Lucia;
Trepp, Roman;
Hoepner, Robert;
Salmen, Anke;
Gerard, Camille L.;
Hruz, Petr;
Christ, Lisa;
Rothschild, Sacha I.

Publication type:

Article

BTLA dysregulation correlates with poor outcome and diminished T cell-mediated antitumor responses in chronic lymphocytic leukemia.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2529, doi. 10.1007/s00262-023-03435-1

By:

Sordo-Bahamonde, Christian;
Lorenzo-Herrero, Seila;
Martínez-Pérez, Alejandra;
Gonzalez-Rodriguez, Ana P.;
Payer, Ángel R.;
González-García, Esther;
Aguilar-García, Candelaria;
González-Rodríguez, Sara;
López-Soto, Alejandro;
García-Torre, Alejandra;
Gonzalez, Segundo

Publication type:

Article

Correction to: CD33 BiTE<sup>®</sup> molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells.

Published in:

2023

By:

Marcinek, Anetta;
Brauchle, Bettina;
Rohrbacher, Lisa;
Hänel, Gerulf;
Philipp, Nora;
Märkl, Florian;
Strzalkowski, Thaddäus;
Lacher, Sonja M.;
Udiljak, Dragica;
Spiekermann, Karsten;
Theurich, Sebastian;
Kobold, Sebastian;
Kischel, Roman;
James, John R.;
Bücklein, Veit L.;
Subklewe, Marion

Publication type:

Correction Notice

Correction to: Multidisciplinary recommendations for essential baseline functional and laboratory tests to facilitate early diagnosis and management of immune‑related adverse events among cancer patients.

Published in:

2023

By:

Özdemir, Berna C.;
Espinosa da Silva, Cristina;
Arangalage, Dimitri;
Monney, Pierre;
Guler, Sabina A.;
Huynh-Do, Uyen;
Stirnimann, Guido;
Possamai, Lucia;
Trepp, Roman;
Hoepner, Robert;
Salmen, Anke;
Gerard, Camille L.;
Hruz, Petr;
Christ, Lisa;
Rothschild, Sacha I.

Publication type:

Correction Notice

Factors impacting the efficacy of the in-situ vaccine with CpG and OX40 agonist.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2459, doi. 10.1007/s00262-023-03433-3

By:

Pieper, Alexander A.;
Spiegelman, Dan V.;
Felder, Mildred A. R.;
Feils, Arika S.;
Tsarovsky, Noah W.;
Zaborek, Jen;
Morris, Zachary S.;
Erbe, Amy K.;
Rakhmilevich, Alexander L.;
Sondel, Paul M.

Publication type:

Article

Preclinical development and evaluation of nanobody-based CD70-specific CAR T cells for the treatment of acute myeloid leukemia.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2331, doi. 10.1007/s00262-023-03422-6

By:

Cheng, Jiali;
Ge, Tong;
Zhu, Xiaojian;
Wang, Jue;
Zeng, Yuhao;
Mu, Wei;
Cai, Haodong;
Dai, Zhenyu;
Jin, Jin;
Yang, Yongkun;
Hu, Guang;
Mao, Xia;
Zhou, Jianfeng;
Zhu, Li;
Huang, Liang

Publication type:

Article

Integrative analyses of bulk and single-cell RNA-seq identified cancer-associated fibroblasts-related signature as a prognostic factor for immunotherapy in NSCLC.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2423, doi. 10.1007/s00262-023-03428-0

By:

Wang, Shasha;
Fan, Guangyu;
Li, Lin;
He, Yajun;
Lou, Ning;
Xie, Tongji;
Dai, Liyuan;
Gao, Ruyun;
Yang, Mengwei;
Shi, Yuankai;
Han, Xiaohong

Publication type:

Article

Correction to: LILRB2-containing small extracellular vesicles from glioblastoma promote tumor progression by promoting the formation and expansion of myeloid-derived suppressor cells.

Published in:

2023

By:

Wu, Peitao;
Guo, Yuhang;
Xiao, Li;
Yuan, Jiaqi;
Tang, Chao;
Dong, Jun;
Qian, Zhiyuan

Publication type:

Correction Notice

Immune checkpoint inhibition combined with targeted therapy using a novel virus-like drug conjugate induces complete responses in a murine model of local and distant tumors.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2405, doi. 10.1007/s00262-023-03425-3

By:

Huis in 't Veld, Ruben V.;
Ma, Sen;
Kines, Rhonda C.;
Savinainen, Anneli;
Rich, Cadmus;
Ossendorp, Ferry;
Jager, Martine J.

Publication type:

Article

MIP3α as an early prognostic predictor for patients with B-cell malignancies receiving CD19/CD22-redirected CAR-T cell cocktail therapy.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2245, doi. 10.1007/s00262-023-03418-2

By:

Jin, Jin;
Liu, Tianjiao;
Cheng, Jiali;
Meng, Jiao;
Wang, Na;
Huang, Liang;
Zhou, Xiaoxi;
Chen, Liting;
Luo, Hui;
Zhou, Jianfeng

Publication type:

Article

First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2443, doi. 10.1007/s00262-023-03430-6

By:

Bendell, Johanna;
LoRusso, Patricia;
Overman, Michael;
Noonan, Anne M.;
Kim, Dong-Wan;
Strickler, John H.;
Kim, Sang-We;
Clarke, Stephen;
George, Thomas J.;
Grimison, Peter S.;
Barve, Minal;
Amin, Manik;
Desai, Jayesh;
Wise-Draper, Trisha;
Eck, Steven;
Jiang, Yu;
Khan, Anis A.;
Wu, Yuling;
Martin, Philip;
Cooper, Zachary A.

Publication type:

Article

A phase I prospective, non-randomized trial of autologous dendritic cell-based cryoimmunotherapy in patients with metastatic castration-resistant prostate cancer.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2357, doi. 10.1007/s00262-023-03421-7

By:

Thomsen, Liv Cecilie Vestrheim;
Honoré, Alfred;
Reisæter, Lars Anders Rokne;
Almås, Bjarte;
Børretzen, Astrid;
Helle, Svein Inge;
Førde, Kristina;
Kristoffersen, Einar Klæboe;
Kaada, Silje Helland;
Melve, Guro Kristin;
Haslerud, Torjan Magne;
Biermann, Martin;
Bigalke, Iris;
Kvalheim, Gunnar;
Azeem, Waqas;
Olsen, Jan Roger;
Gabriel, Benjamin;
Knappskog, Stian;
Halvorsen, Ole Johan;
Akslen, Lars Andreas

Publication type:

Article

Establishment of a novel NFAT-GFP reporter platform useful for the functional avidity maturation of HLA class II-restricted TCRs.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2347, doi. 10.1007/s00262-023-03420-8

By:

Fujiki, Fumihiro;
Morimoto, Soyoko;
Nishida, Yuya;
Tanii, Satoe;
Aoyama, Nao;
Inatome, Miki;
Inoue, Kento;
Katsuhara, Akiko;
Nakajima, Hiroko;
Nakata, Jun;
Nishida, Sumiyuki;
Tsuboi, Akihiro;
Oka, Yoshihiro;
Oji, Yusuke;
Sogo, Shinji;
Sugiyama, Haruo

Publication type:

Article

HER2-targeting antibody–drug conjugate RC48 alone or in combination with immunotherapy for locally advanced or metastatic urothelial carcinoma: a multicenter, real-world study.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2309, doi. 10.1007/s00262-023-03419-1

By:

Chen, Meiting;
Yao, Kai;
Cao, Manming;
Liu, Hao;
Xue, Cong;
Qin, Tao;
Meng, Lingru;
Zheng, Zhousan;
Qin, Zike;
Zhou, Fangjian;
Liu, Zhuowei;
Shi, Yanxia;
An, Xin

Publication type:

Article

IL13Rα2-targeted third-generation CAR-T cells with CD28 transmembrane domain mediate the best anti-glioblastoma efficacy.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2393, doi. 10.1007/s00262-023-03423-5

By:

Gu, Aiqin;
Bai, Yue;
Zhang, Can;
Xu, Chang;
An, Zhijing;
Zhang, Ying;
Zhong, Steven H.;
Hu, Yi;
Zhong, Xiaosong

Publication type:

Article

Efficacy and safety of immune checkpoint inhibitors in elderly patients with primary liver cancer: a retrospective, multicenter, real-world cohort study.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2299, doi. 10.1007/s00262-023-03417-3

By:

Xiao, Lushan;
Liao, Yanxia;
Wang, Jiaren;
Li, Qimei;
Zhu, Hongbo;
Hong, Chang;
Li, Ruining;
He, Jingzhe;
Cui, Hao;
Dong, Hanzhi;
Zeng, Lin;
Liu, Li

Publication type:

Article

Targeting CD73 increases therapeutic response to immunogenic chemotherapy by promoting dendritic cell maturation.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2283, doi. 10.1007/s00262-023-03416-4

By:

Lin, Yun-Shan;
Chiang, Shu-Fen;
Chen, Chia-Yi;
Hong, Wei-Ze;
Chen, Tsung-Wei;
Chen, William Tzu-Liang;
Ke, Tao-Wei;
Yang, Pei-Chen;
Liang, Ji-An;
Shiau, An‑Cheng;
Chao, K. S. Clifford;
Huang, Kevin Chih-Yang

Publication type:

Article

CiTSA: a comprehensive platform provides experimentally supported signatures of cancer immunotherapy and analysis tools based on bulk and scRNA-seq data.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2319, doi. 10.1007/s00262-023-03414-6

By:

Li, Feng;
Dong, Kejing;
Zhang, Chunlong;
Wang, Jingwen;
Tang, Yongjuan;
Xue, Ke;
Zheng, Xuan;
Song, Kaiyue;
Zhang, Xiaomeng;
Li, Mengyue;
Zhao, Rui;
Zhong, Xiaoling;
Xu, Yanjun;
Zhang, Yunpeng;
Li, Xia

Publication type:

Article

M2 tumor-associated macrophages resist to oxidative stress through heme oxygenase-1 in the colorectal cancer tumor microenvironment.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2233, doi. 10.1007/s00262-023-03406-6

By:

Ito, Misato;
Mimura, Kosaku;
Nakajima, Shotaro;
Okayama, Hirokazu;
Saito, Katsuharu;
Nakajima, Takahiro;
Kikuchi, Tomohiro;
Onozawa, Hisashi;
Fujita, Shotaro;
Sakamoto, Wataru;
Saito, Motonobu;
Momma, Tomoyuki;
Saze, Zenichiro;
Kono, Koji

Publication type:

Article

Effectiveness and tolerability of camrelizumab combined with molecular targeted therapy for patients with unresectable or advanced HCC.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2137, doi. 10.1007/s00262-023-03404-8

By:

Li, Ting;
Guo, Jiang;
Liu, Yushen;
Du, Zhaoqing;
Guo, Zhaoyang;
Fan, Yangwei;
Cheng, Long;
Zhang, Yue;
Gao, Xu;
Zhao, Yunyu;
He, Xinyuan;
Wu, Wenhua;
Gao, Ning;
Wu, Yinying;
Li, Jie;
Zhang, Yu;
Kang, Wen;
Cai, Zhifang;
Wang, Wenjun;
Li, Xiaopeng

Publication type:

Article

Identification of antigenic epitopes recognized by tumor infiltrating lymphocytes in high grade serous ovarian cancer by multi-omics profiling of the auto-antigen repertoire.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2375, doi. 10.1007/s00262-023-03413-7

By:

Millar, Douglas G.;
Yang, S. Y. Cindy;
Sayad, Azin;
Zhao, Qingchuan;
Nguyen, Linh T.;
Warner, Kathrin;
Sangster, Ami G.;
Nakatsugawa, Munehide;
Murata, Kenji;
Wang, Ben X.;
Shaw, Patricia;
Clarke, Blaise;
Bernardini, Marcus Q.;
Pugh, Trevor;
Thibault, Pierre;
Hirano, Naoto;
Perreault, Claude;
Ohashi, Pamela S.

Publication type:

Article

Cancer immunity and immunotherapy beyond COVID-19.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2541, doi. 10.1007/s00262-023-03411-9

By:

Bellone, Matteo;
Brevi, Arianna;
Bronte, Vincenzo;
Dusi, Silvia;
Ferrucci, Pier Francesco;
Nisticò, Paola;
Rosato, Antonio;
Russo, Vincenzo;
Sica, Antonio;
Toietta, Gabriele;
Colombo, Mario Paolo

Publication type:

Article

Risk factors indicating immune-related adverse events with combination chemotherapy with immune checkpoint inhibitors and platinum agents in patients with non-small cell lung cancer: a multicenter retrospective study.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2169, doi. 10.1007/s00262-023-03408-4

By:

Fujimoto, Airi;
Koutake, Yoshimichi;
Hisamatsu, Daisuke;
Ookubo, Noriko;
Yabuuchi, Yurika;
Kamimura, Go;
Kai, Tatsuo;
Kozono, Aki;
Ootsu, Takahiro;
Suzuki, Hiroto;
Matsuo, Keisuke;
Kuwahara, Kimiko;
Oiwane, Yoshita;
Nagata, Yuko;
Tanimoto, Kenya;
Sato, Eri;
Suenaga, Mei;
Uehara, Tomohiro;
Ikari, Akira;
Endo, Satoshi

Publication type:

Article

Mitochondrial C1QBP is essential for T cell antitumor function by maintaining mitochondrial plasticity and metabolic fitness.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2151, doi. 10.1007/s00262-023-03407-5

By:

Tian, Hui;
Chai, Dafei;
Wang, Gang;
Wang, Qiping;
Sun, Nan;
Jiang, Guan;
Li, Huizhong;
Song, Jingyuan;
Fang, Lin;
Wang, Meng;
Guo, Zengli;
Zheng, Junnian

Publication type:

Article

Neoadjuvant Camrelizumab for Non-Small Cell Lung Cancer: A Retrospective Multicenter, Real-World Study (CTONG2004).

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2257, doi. 10.1007/s00262-023-03412-8

By:

Liu, Si-Yang;
Chen, Qixun;
Zhou, Chengzhi;
Zhang, Huizhong;
Li, Wen;
Chen, Jianhua;
Hu, Jian;
Wu, Lin;
Chen, Qunqing;
Dai, Qiangsheng;
Shan, Jian-Zhen;
Xu, Fei;
Liu, Si-Yang Maggie;
Wu, Yi-Long

Publication type:

Article

Alanine-based spacers promote an efficient antigen processing and presentation in neoantigen polypeptide vaccines.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2113, doi. 10.1007/s00262-023-03409-3

By:

Aguilar-Gurrieri, Carmen;
Barajas, Ana;
Rovirosa, Carla;
Ortiz, Raquel;
Urrea, Victor;
de la Iglesia, Nuria;
Clotet, Bonaventura;
Blanco, Julià;
Carrillo, Jorge

Publication type:

Article

The 27-gene IO score is associated with efficacy of PD-1/L1 inhibitors independent of FGFR expression in a real-world metastatic urothelial carcinoma cohort.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2075, doi. 10.1007/s00262-023-03401-x

By:

Nielsen, Tyler J.;
Varga, Matthew G.;
Cronister, Catherine T.;
Ring, Brian Z.;
Seitz, Robert S.;
Ross, Douglas T.;
Schweitzer, Brock L.;
McGregor, Kimberly

Publication type:

Article

A randomised controlled trial of long NY-ESO-1 peptide-pulsed autologous dendritic cells with or without alpha-galactosylceramide in high-risk melanoma.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2267, doi. 10.1007/s00262-023-03400-y

By:

Dasyam, Nathaniel;
Sharples, Katrina J.;
Barrow, Catherine;
Huang, Ying;
Bauer, Evelyn;
Mester, Brigitta;
Wood, Catherine E.;
Authier-Hall, Astrid;
Dzhelali, Marina;
Ostapowicz, Tess;
Kumar, Rajiv;
Lowe, Jessica;
Maxwell, Alice;
Burn, Olivia K.;
Williams, Geoffrey M.;
Carley, Sarah E.;
Caygill, Graham;
Jones, Jeremy;
Chan, Susanna T. S.;
Hinder, Victoria A.

Publication type:

Article

Association of medical comorbidities and cardiovascular disease with toxicity and survival among patients receiving checkpoint inhibitor immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2005, doi. 10.1007/s00262-023-03371-0

By:

Johns, Andrew C.;
Yang, Mike;
Wei, Lai;
Grogan, Madison;
Patel, Sandipkumar H.;
Li, Mingjia;
Husain, Marium;
Kendra, Kari L.;
Otterson, Gregory A.;
Burkart, Jarred T.;
Spakowicz, Daniel;
Hoyd, Rebecca;
Owen, Dwight H.;
Presley, Carolyn J.

Publication type:

Article

The role of blood cholesterol quality in patients with advanced cancer receiving immune checkpoint inhibitors.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2127, doi. 10.1007/s00262-023-03398-3

By:

Perrone, Fabiana;
Favari, Elda;
Maglietta, Giuseppe;
Verzè, Michela;
Pluchino, Monica;
Minari, Roberta;
Sabato, Roberto;
Mazzaschi, Giulia;
Ronca, Annalisa;
Rossi, Alessandra;
Cortellini, Alessio;
Pecci, Federica;
Cantini, Luca;
Bersanelli, Melissa;
Quaini, Federico;
Tiseo, Marcello;
Buti, Sebastiano

Publication type:

Article

Effectiveness and safety of radiotherapy plus programmed death-1 inhibitors and lenvatinib in patients with advanced biliary tract carcinoma: a real-world study.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2197, doi. 10.1007/s00262-023-03399-2

By:

Wang, Yunchao;
Yang, Xiaobo;
Wang, Yanyu;
Xue, Jingnan;
Zhang, Nan;
Yang, Xu;
Cong, Ning;
Zhang, Junwei;
Zhu, Chengpei;
Zhang, Longhao;
Hou, Xiaorong;
Zhao, Haitao

Publication type:

Article

Pembrolizumab near the end of life in patients with metastatic pancreatic cancer: a multi-site consecutive series to examine survival and patient treatment burden.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2515, doi. 10.1007/s00262-023-03397-4

By:

Storandt, Michael H.;
Tran, Nguyen;
Martin, Nichole;
Jatoi, Aminah

Publication type:

Article

Expression of soluble CD27 in extranodal natural killer/T-cell lymphoma, nasal type: potential as a biomarker for diagnosis and CD27/CD70-targeted therapy.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2087, doi. 10.1007/s00262-023-03394-7

By:

Nagato, Toshihiro;
Komatsuda, Hiroki;
Hayashi, Ryusuke;
Takahara, Miki;
Kishibe, Kan;
Yasuda, Shunsuke;
Yajima, Yuki;
Kosaka, Akemi;
Ohkuri, Takayuki;
Oikawa, Kensuke;
Harabuchi, Shohei;
Kono, Michihisa;
Yamaki, Hidekiyo;
Wakisaka, Risa;
Hirata-Nozaki, Yui;
Ohara, Kenzo;
Kumai, Takumi;
Katada, Akihiro;
Hayashi, Tatsuya;
Harabuchi, Yasuaki

Publication type:

Article

Clinicopathological significance of peritumoral alveolar macrophages in patients with resected early-stage lung squamous cell carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2205, doi. 10.1007/s00262-023-03393-8

By:

Tanaka, Yu;
Nakai, Tokiko;
Suzuki, Ayako;
Kagawa, Yosuke;
Noritake, Osamu;
Taki, Tetsuro;
Hashimoto, Hiroko;
Sakai, Tetsuya;
Shibata, Yuji;
Izumi, Hiroki;
Nosaki, Kaname;
Udagawa, Hibiki;
Zenke, Yoshitaka;
Matsumoto, Shingo;
Yoh, Kiyotaka;
Miyazaki, Saori;
Sakamoto, Naoya;
Sakashita, Shingo;
Kojima, Motohiro;
Watanbe, Reiko

Publication type:

Article

Efficacy and safety of immune checkpoint inhibitors for hepatocellular carcinoma patients with macrovascular invasion or extrahepatic spread: a systematic review and meta-analysis of 54 studies with 6187 hepatocellular carcinoma patients.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 1957, doi. 10.1007/s00262-023-03390-x

By:

Han, Cheng-Long;
Tian, Bao-Wen;
Yan, Lun-Jie;
Ding, Zi-Niu;
Liu, Hui;
Mao, Xin-Cheng;
Tian, Jin-Cheng;
Xue, Jun-Shuai;
Tan, Si-Yu;
Dong, Zhao-Ru;
Yan, Yu-Chuan;
Hong, Jian-Guo;
Chen, Zhi-Qiang;
Wang, Dong-Xu;
Li, Tao

Publication type:

Article

Cisplatin resistance driver claspin is a target for immunotherapy in urothelial carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2057, doi. 10.1007/s00262-023-03388-5

By:

Yamada, Shuhei;
Miyata, Haruka;
Isono, Makoto;
Hori, Kanta;
Yanagawa, Junko;
Murai, Aiko;
Minowa, Tomoyuki;
Mizue, Yuka;
Sasaki, Kenta;
Murata, Kenji;
Tokita, Serina;
Nakatsugawa, Munehide;
Iwabuchi, Sadahiro;
Hashimoto, Shinichi;
Kubo, Terufumi;
Kanaseki, Takayuki;
Tsukahara, Tomohide;
Abe, Takashige;
Shinohara, Nobuo;
Hirohashi, Yoshihiko

Publication type:

Article

LILRB2-containing small extracellular vesicles from glioblastoma promote tumor progression by promoting the formation and expansion of myeloid-derived suppressor cells.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2179, doi. 10.1007/s00262-023-03395-6

By:

Wu, Peitao;
Guo, Yuhang;
Xiao, Li;
Yuan, Jiaqi;
Tang, Chao;
Dong, Jun;
Qian, Zhiyuan

Publication type:

Article

Anti-PD-1 therapy in advanced sarcomas: is cutaneous primary site a stronger predictor of response than histologic subtype?

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2521, doi. 10.1007/s00262-023-03387-6

By:

Miao, Ruoyu;
Swank, Jennifer;
Melzer, Dan;
Ludlow, Steven;
Clark, Leah;
Finger, Molly;
Reed, Damon R.;
Druta, Mihaela;
Brohl, Andrew S.

Publication type:

Article

Preliminary clinical study of personalized neoantigen vaccine therapy for microsatellite stability (MSS)-advanced colorectal cancer.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2045, doi. 10.1007/s00262-023-03386-7

By:

Yu, Yao-Jun;
Shan, Na;
Li, Li-Yi;
Zhu, Yue-Sheng;
Lin, Li-Miao;
Mao, Chen-Chen;
Hu, Ting-Ting;
Xue, Xiang-Yang;
Su, Xiao-Ping;
Shen, Xian;
Cai, Zhen-Zhai

Publication type:

Article

Mean platelet volume, thrombocytosis, and survival in non-small cell lung cancer patients treated with first-line pembrolizumab alone or with chemotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2067, doi. 10.1007/s00262-023-03392-9

By:

Li, Mingjia;
Zhao, Songzhu;
Lopez, Gabrielle;
Secor, Austin;
Das, Parthib;
Surya, Nitya;
Grogan, Madison;
Patel, Sandip;
Chakravarthy, Karthik;
Miah, Abdul;
Spakowicz, Daniel;
Tinoco, Gabriel;
Li, Zihai;
Wei, Lai;
He, Kai;
Bertino, Erin;
Alahmadi, Asrar;
Memmott, Regan;
Kaufman, Jacob;
Shields, Peter G.

Publication type:

Article

Associations between KIR/KIR-ligand genotypes and clinical outcome for patients with advanced solid tumors receiving BEMPEG plus nivolumab combination therapy in the PIVOT-02 trial.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2099, doi. 10.1007/s00262-023-03383-w

By:

Feils, A. S.;
Erbe, A. K.;
Birstler, J.;
Kim, K.;
Hoch, U.;
Currie, S. L.;
Nguyen, T.;
Yu, D.;
Siefker-Radtke, A. O.;
Tannir, N.;
Tolaney, S. M.;
Diab, A.;
Sondel, P. M.

Publication type:

Article

The role of spatial interplay patterns between PD-L1-positive tumor cell and T cell in recurrence of locally advanced non-small cell lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2015, doi. 10.1007/s00262-023-03380-z

By:

Yang, Liying;
Zhang, Wei;
Sun, Jujie;
Yang, Guanqun;
Cai, Siqi;
Sun, Fenghao;
Xing, Ligang;
Sun, Xiaorong

Publication type:

Article

Overcoming cancer-associated fibroblast-induced immunosuppression by anti-interleukin-6 receptor antibody.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2029, doi. 10.1007/s00262-023-03378-7

By:

Nishiwaki, Noriyuki;
Noma, Kazuhiro;
Ohara, Toshiaki;
Kunitomo, Tomoyoshi;
Kawasaki, Kento;
Akai, Masaaki;
Kobayashi, Teruki;
Narusaka, Toru;
Kashima, Hajime;
Sato, Hiroaki;
Komoto, Satoshi;
Kato, Takuya;
Maeda, Naoaki;
Kikuchi, Satoru;
Tanabe, Shunsuke;
Tazawa, Hiroshi;
Shirakawa, Yasuhiro;
Fujiwara, Toshiyoshi

Publication type:

Article

Tumour microenvironment as a predictive factor for immunotherapy in non-muscle-invasive bladder cancer.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 1971, doi. 10.1007/s00262-023-03376-9

By:

Semeniuk-Wojtaś, Aleksandra;
Poddębniak-Strama, Karolina;
Modzelewska, Magdalena;
Baryła, Maksymilian;
Dziąg-Dudek, Ewelina;
Syryło, Tomasz;
Górnicka, Barbara;
Jakieła, Anna;
Stec, Rafał

Publication type:

Article

Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach.

Published in:

Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2217, doi. 10.1007/s00262-023-03384-9

By:

Botticelli, Andrea;
Cirillo, Alessio;
Pomati, Giulia;
Cortesi, Enrico;
Rossi, Ernesto;
Schinzari, Giovanni;
Tortora, Giampaolo;
Tomao, Silverio;
Fiscon, Giulia;
Farina, Lorenzo;
Scagnoli, Simone;
Pisegna, Simona;
Ciurluini, Fabio;
Chiavassa, Antonella;
Amirhassankhani, Sasan;
Ceccarelli, Fulvia;
Conti, Fabrizio;
Di Filippo, Alessandra;
Zizzari, Ilaria Grazia;
Napoletano, Chiara

Publication type:

Article